[1]
“Lipoprotein (a) in Cardiovascular Risk Assessment and Management in Diabetes Mellitus”, Can Diabetes Endocrinol Today, vol. 1, no. 3, pp. 5–9, Oct. 2023, doi: 10.58931/cdet.2023.1315.